NCT00667082 2017-11-22NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or LymphomaCelgenePhase 1 Completed22 enrolled
NCT01386398 2015-01-21Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell LymphomaEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 3 Withdrawn
NCT00787527 2014-09-09SAHA + CHOP in Untreated T-cell Non-Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 1/2 Completed14 enrolled 8 charts
NCT00005634 2013-06-19Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT00810576 2012-08-07Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 2 Terminated1 enrolled 3 charts